Current MEG Announcements
MEG Annual Dues Elimination / Optional Donations for the MEG Scholar-in-Training Awards (SITAs) Requested
The epidemiology community is collaborative by its very nature. To ensure maximal participation by all interested, the MEG and AACR leadership have removed MEG dues beginning with the 2020 dues renewal cycle beginning in September 2019. The majority of these dues supported the three MEG Scholar-in-Training Awards. Please consider a donation to the MEG Scholar-in-Training fund when renewing or initiating your membership. For assistance, contact firstname.lastname@example.org. Thank you for your continued support of early-career scholars!
Plan to attend the MEG events at the AACR Annual Meeting 2020
Be sure to watch for updated information on the AACR Annual Meeting 2020 and how you can register and reserve lodging! We especially look forward to seeing you at the MEG events being planned to take place there.
Remember that early registration is open until Dec. 20, 2019!
Reserve your Epidemiology Consortium Meeting Room at the AACR Annual Meeting 2020!
For the eighth consecutive year, the AACR-MEG Leadership is pleased to provide MEG members with this benefit, free-of-charge. The room will be scheduled on a first-come, first-served basis. For further details and how to apply, see here. We look forward to accommodating your meeting!
Fifth International Molecular Pathological Epidemiology (MPE) Meeting, June 4-5, 2020, Dana-Farber Cancer Institute, Boston, Massachusetts
Drs. Shuji Ogino; Christine Ambrosone; Peter T. Campbell; Montserrat Garcia-Closas; and Timothy Rebbeck, Cochairs, cordially invite you to participate in this Meeting which is free-of-charge to all registrants. Keynote speakers are Drs. Todd Golub (Director, Cancer Program of Broad Institute) and Stephen Chanock (Director, Division of Cancer Epidemiology and Genetics, NCI, NIH). See the program; further details will be posted when confirmed. Registration and abstract submission sites are open, with abstracts and poster sessions conducted as "retreat style." Abstracts may be submitted that have been submitted/presented elsewhere or will be submitted elsewhere, without any copyright issue. We will NOT put any copyright on your abstract or officially publish your abstract. Top abstracts can be selected as short lectures. To learn more, please visit the MPE Meeting website. For questions, please feel free to contact the meeting Cochairs or the meeting Secretary, Ms. Martina Bragg.
From the Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
The Epidemiology and Genomics Research Program in NCI’s Division of Cancer Control and Population Sciences invites AACR-MEG members to register for upcoming webinars.To learn more about the EGRP's webinar series, visit the SeqSPACE Upcoming Topics and Speakers webpage. Upcoming presentations include:
Lessons Learned Sequencing Precancerous Lesions
Dec. 17, 2019, 3 to 4 p.m. ET
Jennifer Beane, PhD
Dr. Jennifer Beane is an Assistant Professor of Medicine in the section of Computational Biomedicine at Boston University School of Medicine. Her research interests include smoking effects on airway epithelial gene expression; gene expression-based diagnostic for lung cancer; and lung cancer chemoprevention and understanding biology associated with the development of lung squamous premalignant lesions. In this webinar, Dr. Beane will be presenting on lessons learned sequencing precancerous lesions.Register for this webinar
Research Identifying Germline Predisposition Variants in Sequencing Studies
Feb. 4, 2020, 3 to 4:30 p.m. ET
Fernanda Martins Rodrigues, MSc
Ms. Fernanda Martins Rodrigues is a PhD student in molecular genetics at Washington University in Saint Louis working with Dr. Li Ding at the Ding Lab External Web Site Policy. The goal of her research is to use computational tools to better understand cancer genetics. In this webinar, Ms. Martins Rodrigues will be presenting on research identifying germline predisposition variants in sequencing studies.Register for this webinar
Transdisciplinary (TD) Training Opportunity in Energetics and Cancer!
This is the fourth year of building a diverse community of TD researchers, including those interested in cancer disparities. We invite you to apply to our mentored program: The Transdisciplinary Research on Energetics and Cancer (TREC) Training Workshop.
The Workshop builds upon the NCI TREC Initiative and covers topics across the cancer control and T0-T4 continuua.
Funded by the USA's National Cancer Institute and led by Yale University’s Dr. Melinda Irwin, with a Senior Advisory Board and expert international faculty, this program builds capacity in TD energetics and cancer research and is designed for early career investigators (i.e., junior faculty and postdocs). This five-day, in-residence Workshop is offered annually and places emphasis on developing and applying TD competencies focused on energetics (i.e. obesity, diet and exercise) and cancer. Faculty span an array of professional disciplines, from basic scientists to clinicians to behavioral and population scientists. Formal didactic learning is integrated with one-on-one dialog and small group discussions to enable fellows to learn from each other, from faculty, and to develop a TD network.
The 4th annual course will be held June 21-26, 2020 at Water’s Edge Resort, Westbrook, Connecticut, USA.
Our grant allows us to accept up to 10 per cent of our cohort from international applicants (hence, up to two international scholars as our cohort size is 20 fellows). Per our funding grant, all applicants’ proposals must be “strongly justified on the basis of exceptional relevance to the United States National Institutes of Health.” Limited funding for airfare for international travelers is available. All rooming costs are covered. Each year to-date, we have accepted at least one international fellow.
Notification of Intent to apply (very simple, informal email) is due no later than Monday, Dec. 16, 2019. Full application is due no later than Wed., January 15, 2020.
Be Sure to See the AACR Blog: Cancer Research Catalyst!
See current scientific research updates in the AACR's blog Cancer Research Catalyst, and learn how you can submit content!
Request for Proposals for Genome-wide Investigation of Late-effects Using the Childhood Cancer Survivor Study (CCSS) Cohort
The Childhood Cancer Survivor Study (CCSS) is an NCI-funded resource for the study of long-term survivors of cancer diagnosed during childhood and adolescence. Learn the details regarding the cohort.
Members of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute and CCSS investigators collaborated to conduct a genome-wide association study, initially intended to study the role of genetic susceptibility in the development of subsequent neoplasms as well as first primary childhood cancers using samples from the CCSS Biorepository. Genotyping was conducted for 5739 childhood cancer survivors diagnosed 1970-1986 (5324 are of European ancestry) using the Illumina HumanOmni5Exome microarray, with over 4.1 million loci passing quality control thresholds (based on locus and sample missing rates, sample heterozygosity, and sex discrepancies).
The CCSS leadership is now broadening the scope of this initiative to study the role of genetic susceptibility in the development of non-malignant, treatment-related outcomes in cancer survivors. Accordingly, CCSS is announcing a request for proposals to collaborate with CCSS and NCI investigators in the use of existing genome-wide association study (GWAS) data and corresponding outcomes-related data to address innovative research questions relating to potential genetic contributions to risk for non-malignant treatment-related outcomes. Requests will be accepted on an ongoing basis and will be reviewed three times per year, in February, June, and October (cut-off for receipt of applications February 1, June 1, October 1).
Learn more details regarding the application process as well as the application for data access.
MEG Members Receive an Additional 5 Percent Discount on CEBP Accepted Manuscripts
MEG members receive a special 5 percent discount for publication fees only (not AuthorChoice) for articles accepted in Cancer Epidemiology, Biomarkers & Prevention (CEBP). This is in addition to the 5 percent discount given to all AACR members. Thus, MEG members receive a total discount of 10 percent. Just use the code "MEGAO2019" when receiving notification from the CEBP staff about author billing. See the information for authors for CEBP submissions. We look forward to receiving your submission.
CancerCareers Discounts Available
Be sure to check out www.cancercareers.org for career opportunities. MEG members now receive a 15 percent discount for all employment postings. Use the code MEGAD when submitting your advertisement to receive this special rate. You can also sign-up for job alerts and refine a job search by a specific research area, i.e. epidemiology; prevention. Look on the right side of the website for these options.
To Submit an Announcement for Consideration, Please Note:
Employment opportunities should be sent to cancercareers.org for posting consideration on that website. Please refer all questions regarding employment posting to
Postings of a non-employment nature may still be sent to email@example.com for review and possible future posting on the MEG Announcements.
Best regards from everyone at the AACR, and sincere appreciation for your